The EANM guideline for radiosynoviorthesis

Kampen W. U., Boddenberg-Paetzold B., Fischer M., Gabriel M., Klett R., Konijnenberg M., ...Daha Fazla

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.49, sa.2, ss.681-708, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s00259-021-05541-7
  • Dergi Adı: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Biotechnology Research Abstracts, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.681-708
  • Anahtar Kelimeler: Synovitis, Arthritis, Radiosynoviorthesis, MODIFYING ANTIRHEUMATIC DRUGS, CHRONIC HEMOPHILIC SYNOVITIS, UPPER EXTREMITY JOINTS, LONG-TERM EVALUATION, NERVE GROWTH-FACTOR, RADIATION SYNOVECTOMY, RHEUMATOID-ARTHRITIS, RADIONUCLIDE SYNOVECTOMY, BIOLOGICAL DOSIMETRY, Y-90 SYNOVECTOMY
  • İstanbul Üniversitesi Adresli: Evet

Özet

Purpose Radiosynoviorthesis (RSO) using the intraarticular application of beta-particle emitting radiocolloids has for decades been used for the local treatment of inflammatory joint diseases. The injected radiopharmaceuticals are phagocytized by the superficial macrophages of the synovial membrane, resulting in sclerosis and fibrosis of the formerly inflamed tissue, finally leading to reduced joint effusion and alleviation of joint pain.